High Tower Advisors, LLC Scynexis Inc Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$3.56 - $6.66 $4,450 - $8,325	-1,250 Reduced 11.08%	10,030 $39,000
Q4 2021 Feb 10, 2022	BUY	$4.94 - $7.69 $148 - $230	30 Added 0.27%	11,280 $69,000
Q2 2021 Aug 06, 2021	SELL	$6.5 - $9.97 $240 - $368	-37 Reduced 0.33%	11,250 $83,000
Q1 2021 May 10, 2021	BUY	$6.93 - $9.63 $8,662 - $12,037	1,250 Added 12.45%	11,287 $89,000
Q4 2020 Feb 10, 2021	SELL	$4.28 - $7.87 $4,121 - $7,578	-963 Reduced 8.75%	10,037 $77,000

Q3 2020 Nov 13, 2020	BUY	$4.37 - $7.48 $48,070 - $82,280	11,000 New	11,000 $48,000

15.4M

12.9K

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $63.7M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.